Pharmafile Logo

OPEN Health Group Appoints New Leadership

November 18, 2020 |  

OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A portfolio company of Amulet Capital Partners, LP, OPEN Health is a leading multi-disciplinary health communications and market access group.

Mr. Barker has approximately 30 years of executive leadership experience in the biopharmaceuticals industry, including multiple roles at leading medical communications and strategy consulting firms. Most recently, he served as CEO of OPEN Health’s Medical Communications practice, having joined the business six years ago.

Mr. Barker expressed his enthusiasm for the continued growth and success of OPEN Health: “I am excited to be leading such a talented and expert team who have been instrumental in growing OPEN Health to its current position. We are now in a place to take even greater strides forward, and I feel confident that our continued focus on client service and scientific excellence will drive increased growth in the business.”

“Rob Barker has proven himself as an outstanding strategic and operational leader, and we are confident that he is the ideal executive to lead OPEN Health through its next exciting stage of growth,” said Ramsey Frank, Managing Partner and co-founder of Amulet. Amulet Partner Nick Amigone added, “Medical Affairs, Medical Communications, Market Access and HEOR have taken on increasingly important roles in bringing new therapies to market. Rob has been instrumental in assembling a suite of best-in-class capabilities at OPEN Health and driving the business to achieve its full potential.”

Mr. Frank added, “David Rowley leaves the business with our enormous thanks. He has grown OPEN Health from an initial idea to a leading global healthcare communications group. All his colleagues at OPEN Health are grateful to him and wish him well for the future. David will work with us in an advisory capacity to ensure a smooth transition.”

Mr. Rowley said “I have been CEO of OPEN Health since its inception, and I am incredibly proud of the company that we have built. This is the right time for me to be stepping down, and I wish Rob and the whole OPEN Health team continued success.”

Pink divider

About OPEN Health

OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines.

For more information on OPEN Health, please visit www.openhealthgroup.com.

About Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million.

For additional information, please visit www.amuletcapital.com.

Pink divider

Contacts for OPEN Health:

EU: Carwyn Jones 
carwynjones@openhealthgroup.com
+44 20 3386 4728

USA: Candice Subero
csubero@openhealthgroup.com
+1 240-483-4323

Contact for Amulet Capital Partners:

Melissa Sheer 
melissa@kentplacellc.com
+1 917-690-2199

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Embracing the Patient Voice Within Publications

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

Navigating the nocebo effect through patient engagement is the key to setting patients up for success

If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.